AUGUST 2024LIFE SCIENCES REVIEW4CONTENTSCONTENTSHistorical control in gene therapy clinical developmentHaichen Yang, MD, MA, MBA, Vice President, Clinical Research, Amicus Therapeutics Inc [NASDAQ: FOLD]IN MY OPINION0834LAST WORDCOVER STORY 12Gene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and InnovationRachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corporation [NASDAQ: RGEN]TOP 10COMPANIES 2025BiotechOSSIFI THERAPEUTICSBUILDING A BETTER FUTURE FOR BONE HEALTHDebra L. Ellies,CEO
< Page 3 | Page 5 >